Professor; Vice Chair of Education and Residency Program Director
University of California, Davis, School of Medicine
Sacramento, California, United States
● Amgen (Currently Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds) ● Eli Lily (Currently Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds) ● Johnson & Johnson (Currently Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds) ● Merck (Currently Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds) ● Organon (Currently Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds) ● Proctor and Gamble (Currently Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds)
Monday, April 25, 2022
11:15 AM – 11:30 AM US MT